University of Florida Health Cancer Center Support Grant
佛罗里达大学健康癌症中心支持补助金
基本信息
- 批准号:10625750
- 负责人:
- 金额:$ 213.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-01 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AbbreviationsAchievementAddressAgingAgricultureAmerican Cancer SocietyAreaArtsBasic Cancer ResearchBiologyBiomedical ResearchBiometryBlack raceBreastBudgetsCancer BurdenCancer CenterCancer Center Support GrantCancer ControlCancer EtiologyCancer Research ProjectCancer VaccinesCatchment AreaCellsClassificationClinicClinicalClinical Cancer CenterClinical InvestigatorClinical ResearchClinical SciencesClinical Trials NetworkCollaborationsColorectalCommunicationCommunitiesCommunity OutreachComplexConfocal MicroscopyCountyData SetDentistryDevelopmentDevelopmental Therapeutics ProgramDiagnosisDiscipline of NursingDiseaseDiverse WorkforceEducational ActivitiesEngineeringFacultyFloridaFlow CytometryFosteringFundingGenetic ResearchGoalsHealthHealth OccupationsHealth SciencesHispanicHumanHuman Papilloma Virus VaccinationImmune responseImmunotherapyInstitutionInterventionIntervention TrialJournalismLaboratoriesLast NameLeadLungMalignant NeoplasmsMedically Underserved AreaMedicineMentorshipMissionMolecular CarcinogenesisNCI Center for Cancer ResearchNCI-Designated Cancer CenterNew EnglandOncoproteinsOutcomePatientsPeer ReviewPerformancePersonsPharmacy facilityPlayPopulationPopulation SciencesPreclinical TestingPreventionPrevention strategyPrevention trialPublic HealthPublicationsRNARegional CancerResearchResearch PersonnelResearch Project GrantsResource SharingResourcesRuralScienceScientific Advances and AccomplishmentsScientistScreening for cancerShapesSiteStrategic PlanningTalentsTeacher Professional DevelopmentTechnologyTestingTextTherapeuticTobacco useTrainingTraining ProgramsTranslatingTranslational ResearchTranslationsUnderrepresented MinorityUniversitiesWomanWorkforce Developmentanticancer researchcancer health disparitycancer preventioncancer therapycareercareer developmentclinically relevantcohortcollegecommunity engagementdiversity and inclusionequity, diversity, and inclusionhealth literacyhigh schoolimprovedinnovationinvestigator-initiated trialleadership developmentleukemiamarine organismmembermicrobiomenext generationnext generation sequencingnovelpersonalized medicinepopulation basedpreventprogramsrecruitrural countiesscreeningsmall moleculesmoking cessationsurvivorshiptargeted treatmenttreatment responsetumorigenesis
项目摘要
OVERALL: ABSTRACT
In recognition of achievements in fostering transdisciplinary research, inclusive workforce development,
community engagement, and ability to enhance its impact on the catchment area (CA), the University of Florida
Health Cancer Center (UFHCC) seeks NCI-Designation. UFHCC is a matrix center that supports cancer
research and career enhancement across all 6 UF health sciences colleges (Dentistry, Medicine, Nursing,
Pharmacy, Public Health & Health Professions, and Veterinary Med) and 5 other UF colleges (Agriculture,
Engineering, Health & Human Performance, Journalism & Communications, and Liberal Arts & Sciences).
Collaborative research is conducted by 147 members across 3 UFHCC scientific programs: Mechanisms of
Oncogenesis, Cancer Therapeutics and Host Response, and Cancer Control and Population Sciences. The
UFHCC provides access to state-of-the-art technologies and research expertise for its members through 3
shared resources: Biostatistics and Quantitative Sciences, Flow Cytometry and Confocal Microscopy, and Next
Generation Sequencing. The UFHCC CA includes 23 contiguous counties in North Central Florida spanning
~17,500 mi2, about the size of Southern New England. Most of the counties (16) are rural and every county is
classified as a Medically Underserved Area. The CA population is 2.2M and includes people who are Black
(16%), Hispanic (10%), and has the highest fraction (23%) of residents ≥65 years in Florida. Through community
outreach, UFHCC supports efforts to increase health literacy, prevention, screening, and research engagement.
The UFHCC Clinical Research Office coordinates all cancer-relevant clinical research at UF, which includes a
state-wide clinical trial network. IITs are facilitated through disease site groups with an IIT Think Tank that fosters
clinician collaboration with basic and population scientists. UFHCC innovations translated to the clinic include
targeted therapies, novel immunotherapies, therapeutic modulation of the microbiome, and new strategies to
communicate with patients. UFHCC Developmental Funds seed early-stage research, support recruitment of
new faculty, and build transdisciplinary teams. UFHCC offers inclusive research career enhancement programs
across the learner spectrum. Since 2016, the UFHCC recruited 58 new members (45 external, 39 early-stage)
(45% women, 17% URM). Peer-reviewed funding increased from $21M in 2016 to $32.6M/yr in 2021 (up 55%);
NCI $9.6M to $13.2M (up 37%). Accruals to all interventional trials rose from 515 in 2016 to 1,748 in 2021 (up
3.4-fold). Institutional support of a $32M/year budget over the next 5 years and 44,000ft2 of new research space
will allow UFHCC to expand. The new UFHCC strategic plan, Momentum 2027, has 4 pillars: 1) conduct
transdisciplinary research (RNA biology, microbiome); 2) translate UFHCC discoveries to trials (immunotherapy,
small molecules, cancer communication); 3) address cancer burden (cancer and aging, cancer health
disparities); and, 4) train a prepared and diverse cancer research workforce, including leadership development.
UFHCC is poised to make a major impact on the cancer burden of the catchment area, Florida, and beyond.
总体:摘要
认识到培养跨学科研究的成就,包容性劳动力发展,
社区参与以及增强其对集水区(CA)的影响的能力,佛罗里达大学
健康癌症中心(UFHCC)寻求NCI设计。 UFHCC是支持癌症的基质中心
所有6所UF健康科学学院的研究和职业增强(牙科,医学,护理,
药房,公共卫生与卫生专业人员以及兽医医学)和其他5所UF学院(农业,
工程,健康与人类绩效,新闻与传播以及文科与科学)。
协作研究由3个UFHCC科学计划的147名成员进行:
肿瘤发生,癌症治疗和宿主反应以及癌症控制和人群科学。这
UFHCC通过3提供了对其成员的最先进技术和研究专业知识的访问权限
共享资源:生物统计学和定量科学,流式细胞术和共聚焦显微镜,然后
生成测序。 UFHCC CA包括佛罗里达州中部的23个连续县
〜17,500 mi2,大约是新英格兰南部的大小。大多数县(16)都很粗糙,每个县都是
归类为医疗服务不足的地区。 CA人口为220万,包括黑人的人
(16%),西班牙裔(10%),在佛罗里达州≥65岁的居民的分数最高(23%)。通过社区
UFHCC推广,支持提高健康素养,预防,筛查和研究参与的努力。
UFHCC临床研究办公室协调UF的所有与癌症相关的临床研究,其中包括
全州临床试验网络。 IIT是通过疾病站点组制备的,该疾病部门具有促进的IIT智囊团
与基本和人群科学家的临床合作。 UFHCC创新转化为诊所包括
有针对性的疗法,新型免疫疗法,微生物组的治疗调节以及新的策略
与患者沟通。 UFHCC开发基金会种子早期研究,支持招募
新教师,并建立跨学科团队。 UFHCC提供包容性研究职业增强计划
跨学习者频谱。自2016年以来,UFHCC招募了58名新成员(45位外部,39个早期阶段)
(45%女性,17%URM)。同行评审的资金从2016年的2100万美元增加到2021年/年的3260万美元(增长了55%);
NCI $ 960万美元至1320万美元(增长37%)。所有介入试验的应计值从2016年的515次上升到2021年的1,748(UP
3.4倍)。在未来5年内的3200万美元预算和44,000FT2的机构支持新研究领域
将允许UFHCC扩展。新的UFHCC战略计划,动量2027,有4个支柱:1)行为
跨学科研究(RNA生物学,微生物组); 2)将UFHCC发现转化为试验(免疫疗法,
小分子,癌症传播); 3)解决癌症伯恩(癌症与衰老,癌症健康
差异); 4)培训一名准备好的和潜水的癌症研究人员,包括领导力发展。
UFHCC被中毒,对佛罗里达州集水区及其他地区的癌症伯恩(Cancer Burnen)产生重大影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan D. Licht其他文献
HLA-DR, CD33<sup>+</sup>, CD56<sup>+</sup>, CD16<sup>-</sup> Myeloid/Natural Killer Cell Acute Leukemia: A Previously Unrecognized Form of Acute Leukemia Potentially Misdiagnosed as French-American-British Acute Myeloid Leukemia-M3
- DOI:
10.1182/blood.v84.1.244.244 - 发表时间:
1994-07-01 - 期刊:
- 影响因子:
- 作者:
Amy A. Scott;David R. Head;Kenneth J. Kopecky;Frederick R. Appelbaum;Karl S. Theil;Michael R. Grever;l-Ming Chen;Michael H. Whittaker;Barbara B. Griffith;Jonathan D. Licht;Samuel Waxman;Margaret M. Whalen;Arthur D. Bankhurst;Lynn C. Richter;Thomas M. Grogan;Cheryl L. Willman - 通讯作者:
Cheryl L. Willman
Compound Loss of <em>Dnmt3a</em> and <em>Kmt2c</em> in Myeloid Malignancies
- DOI:
10.1182/blood-2023-189411 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Prabhjot Kaur;Cassandra Berntsen;James Leonard;Daniil Shabashvili;Qingchen Yuan;Bowen Yan;Richard Lynn Bennett;Alberto Riva;Jonathan D. Licht;Olga A. Guryanova - 通讯作者:
Olga A. Guryanova
Synergistic Effect of Trifluridine and PARPi Combination in Targeting <em>TP53</em>-Mutated AML
- DOI:
10.1182/blood-2024-201781 - 发表时间:
2024-11-05 - 期刊:
- 影响因子:
- 作者:
Phani Krishna Parcha;Vivek M. Shastri;Jonathan D. Licht;Jatinder K. Lamba - 通讯作者:
Jatinder K. Lamba
Sprouty1 Controls Genitourinary Development via its N-Terminal Tyrosine.
Sprouty1 通过其 N 端酪氨酸控制泌尿生殖系统的发育。
- DOI:
10.1681/asn.2018111085 - 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
M. Vaquero;S. Cuesta;C. Anerillas;Gisela Altés;J. Ribera;M. Albert Basson;Jonathan D. Licht;J. Egea;M. Encinas - 通讯作者:
M. Encinas
Activating <em>NSD2</em> Mutations Drive Oncogenic Reprogramming By Disturbing Epigenetic Landscape in Mantle Cell Lymphoma
- DOI:
10.1182/blood-2023-189748 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Jianping Li;Marta Kulis;Alberto Riva;Heidi Casellas Román;Daphne Dupere-Richer;Monica Clerio;Melanie L. Trejo;Michael Menes;Anthony Joseph Lamberto;Amin Sobh;Charlotte Leonie Kaestner;Richard Lynn Bennett;Iñaki I. Martin Subero;Jonathan D. Licht - 通讯作者:
Jonathan D. Licht
Jonathan D. Licht的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan D. Licht', 18)}}的其他基金
UF Health Cancer Center Support Grant - Training Navigator Supplement
佛罗里达大学健康癌症中心支持补助金 - 培训导航补充
- 批准号:
10892335 - 财政年份:2023
- 资助金额:
$ 213.5万 - 项目类别:
Exploring microRNA degradation in T-cell acute lymphoblastic leukemia
探索 T 细胞急性淋巴细胞白血病中的 microRNA 降解
- 批准号:
10717486 - 财政年份:2023
- 资助金额:
$ 213.5万 - 项目类别:
Defining and targeting epigenetic plasticity-driven drug resistance and immune escape in melanoma
定义和针对黑色素瘤中表观遗传可塑性驱动的耐药性和免疫逃逸
- 批准号:
10666665 - 财政年份:2022
- 资助金额:
$ 213.5万 - 项目类别:
KDM6A mutation as an epigenetic driver of multiple myeloma
KDM6A 突变作为多发性骨髓瘤的表观遗传驱动因素
- 批准号:
10229675 - 财政年份:2020
- 资助金额:
$ 213.5万 - 项目类别:
2019 Cancer Genetics and Epigenetics GRC/GRS
2019年癌症遗传学和表观遗传学GRC/GRS
- 批准号:
9754282 - 财政年份:2019
- 资助金额:
$ 213.5万 - 项目类别:
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
MMSET 在淋巴恶性肿瘤发病机制和进展中的作用
- 批准号:
9330809 - 财政年份:2016
- 资助金额:
$ 213.5万 - 项目类别:
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
MMSET 在淋巴恶性肿瘤发病机制和进展中的作用
- 批准号:
9759647 - 财政年份:2016
- 资助金额:
$ 213.5万 - 项目类别:
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer
癌症中染色质的时空组织和信息传递
- 批准号:
8866966 - 财政年份:2015
- 资助金额:
$ 213.5万 - 项目类别:
相似国自然基金
共和盆地东北部地区隆升剥蚀过程对干热岩形成就位的影响:来自低温热年代学的制约
- 批准号:42202336
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
朱鹮野生种群营养生态位对繁殖成就的影响及保护对策研究
- 批准号:32270554
- 批准年份:2022
- 资助金额:54.00 万元
- 项目类别:面上项目
朱鹮野生种群营养生态位对繁殖成就的影响及保护对策研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
共和盆地东北部地区隆升剥蚀过程对干热岩形成就位的影响:来自低温热年代学的制约
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成就目标视角下建言韧性的形成机制与作用效果研究
- 批准号:72102228
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Sex Differences in Psychosocial and Neurocognitive Outcomes in Adults with Moderate to Complex Congenital Heart Disease
患有中度至复杂先天性心脏病的成人心理社会和神经认知结果的性别差异
- 批准号:
10825104 - 财政年份:2023
- 资助金额:
$ 213.5万 - 项目类别:
Predictive markers for personalized therapy in chronic lymphocytic leukemia
慢性淋巴细胞白血病个体化治疗的预测标记
- 批准号:
10591089 - 财政年份:2023
- 资助金额:
$ 213.5万 - 项目类别:
Cancer Control and Population Sciences Research Program
癌症控制与人口科学研究计划
- 批准号:
10625755 - 财政年份:2023
- 资助金额:
$ 213.5万 - 项目类别:
Mechanisms underlying regulation of intestinal epithelial homeostasis in sepsis
脓毒症肠上皮稳态调节的机制
- 批准号:
9901333 - 财政年份:2020
- 资助金额:
$ 213.5万 - 项目类别: